Urinary Bladder Cancer.
Urinary Bladder Cancer is Most Commonly Diagnosed at an Early Stage because Bleeding is the First Symptom of Urinary Bladder Cancer.
#cancer #health #bladdercancer #cancerrisk #drmanishsinghal #healthylifestyle
Its main treatment is TURBT, which means Transurethral Resection of the Bladder Tumor,
BCG, we all know, which is a vaccination of TB,
Bladder cancers are often very aggressive and spread.
This can happen in about 20-30 % of people.
And when the patient reaches the late stage, chemotherapy is often used.
The first drug that increases survival and can also cure some people in the long term is Immunotherapy.
Pembrolizumab, which is a type of PD-1 inhibitor.
Immunotherapy is widely used and it gives much better responses.
N4-2Mab betutin, which is a type of ADC, Antibody Drug Conjugate.
It has been designated as a breakthrough therapy from the United States.
This therapy is not yet available in India, but it can be imported and ordered.
It is called N4-2Mab betutin.
Sacituzumab Govitecan
This is also an ADC, and it targets the TROP2 receptor, which is regulated in bladder cancers. upregulated.
When this medicine is mixed with TROP2, that is, this antibody mixes with TROP2, as soon as it binds with it, it also lodges its drug. Chemotherapy drug, which damages a lot of cells and cancer can be controlled.
Erdafitinib
Erdafitinib is a tablet-form therapy that works against FGFR mutation, that is, fibroblast growth factor mutation, which is found in about 15-20 % of people who are suffering from bladder cancer.
That Early Detection is the key if we do not ignore our symptoms and get a timely test done then we may not need any of these therapies because all these therapies are very expensive, capable but also very expensive.